Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
Clinical trial NCT05280717 · TERMINATED
Trial details
- NCT number
- NCT05280717
- Sponsor
- Vir Biotechnology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2023-04-05
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.